Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia

Science

Volumn 319, Issue 5861, 2008, Pages 336-339

  Hong, Dengli ^a   Gupta, Rajeev ^a   Ancliff, Philip ^b   Atzberger, Ann ^a   Brown, John ^a   Soneji, Shamit ^a   Green, Joanne ^a   Colman, Sue ^e   Piacibello, Wanda ^d   Buckle, Veronica ^a   Tsuzuki, Shinobu ^c   Greaves, Mel ^e   Enver, Tariq ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d CANDIOLO CANCER INSTITUTE   (Italy)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SYSTEM DISORDER; CANCER; CHILD HEALTH; CLONE; CYTOLOGY; MUTATION; SURVIVAL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL COMPARTMENTALIZATION; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CORD BLOOD STEM CELL TRANSPLANTATION; FUSION GENE; HUMAN; LEUKEMOGENESIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD19; ANTIGENS, CD34; ANTIGENS, CD38; APOPTOSIS; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASES IN TWINS; FEMALE; FETAL BLOOD; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; PRELEUKEMIA; RECOMBINATION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TWINS, MONOZYGOTIC;

MUS;

EID: 38349183668     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1150648     Document Type: Article

References (22)

1. J. C. Wang, J. E. Dick, Trends Cell Biol. 15, 494 (2005).
2. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, M. F. Clarke, Proc. Natl. Acad. Sci. U.S.A. 100, 3983 (2003).
3. D. Bonnet, J. E. Dick, Nat. Med. 3, 730 (1997).
4. C. F. Kim et al., Cell 121, 823 (2005).
5. S. K. Singh et al., Nature 432, 396 (2004).
6. C. A. O'Brien, A. Pollett, S. Gallinger, J. E. Dick, Nature 445, 106 (2007).
7. P. N. Kelly, A. Dakic, J. M. Adams, S. L. Nutt, A. Strasser, Science 317, 337 (2007).
8. S. A. Shurtleff et al., Leukemia 9, 1985 (1995).
9. M. F. Greaves et al., Blood 102, 2321 (2003).
10. M. F. Greaves, J. Wiemels, Nat. Rev. Cancer 3, 639 (2003).
11. H. Mori et al., Proc. Natl. Acad. Sci. U.S.A. 99, 8242 (2002).
12. C. G. Mullighan et al., Nature 446, 758 (2007).
13. T. R. Golub et al., Proc. Natl. Acad. Sci. U.S.A. 92, 4917 (1995).
14. C. V. Cox et al., Blood 104, 2919 (2004).
15. A. A. George et al., Blood 97, 3925 (2001).
16. M. Hotfilder et al., Blood 100, 640 (2002).
17. A. Castor et al., Nat. Med. 11, 630 (2005).
18. -/low to reflect the observation that CD38 expression in human cells is seen as a continuum rather than existing in discrete populations.
19. Materials and methods are available as supporting material on Science Online.
20. M. F. Greaves et al., Blood 61, 628 (1983).
21. J. Zuna et al., Clin. Cancer Res. 10, 5355 (2004).
22. We thank I. Titley, C. Waugh, and C. Hetherington for technical assistance. This work was supported by a Specialist Programme Grant from the Leukemia Research Fund, the Medical Research Council, and EuroCSC: Targeting Cancer Stem Cells (CSCs) for Therapy.